|Articles|March 8, 2017
Almac Diagnostics, EORTC Collaborate for Tumor Profiling
Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples.
Advertisement
Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples from their clinical trial data and that of pan-European Cancer network, SPECTA.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Reframing the IND: From Tactical Requirement to Strategic Opportunity
4
Labels That Withstand Liquid Nitrogen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
